A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-Dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma
Experimental Hematology and Oncology - United Kingdom
doi 10.1186/s40164-018-0110-0
Full Text
Open PDFAbstract
Available in full text
Date
August 13, 2018
Authors
Publisher
Springer Science and Business Media LLC